IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,572,667 | +101.6% | 67,014 | -0.4% | 0.00% | – |
| Q2 2023 | $1,276,150 | +30.0% | 67,272 | +6.3% | 0.00% | – |
| Q1 2023 | $981,426 | +98042.6% | 63,277 | +51344.7% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 123 | -76.3% | 0.00% | – |
| Q2 2022 | $2,000 | -98.1% | 520 | -95.8% | 0.00% | – |
| Q4 2021 | $105,000 | – | 12,423 | +23339.6% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 53 | -99.8% | 0.00% | – |
| Q2 2021 | $321,000 | -68.1% | 30,410 | -51.5% | 0.00% | – |
| Q1 2021 | $1,006,000 | -45.7% | 62,697 | +56.3% | 0.00% | – |
| Q4 2020 | $1,853,000 | -17.8% | 40,116 | -37.4% | 0.00% | -100.0% |
| Q3 2020 | $2,254,000 | +114.9% | 64,047 | +48.7% | 0.00% | – |
| Q2 2020 | $1,049,000 | – | 43,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |